Home > Healthcare > Biotechnology > Biotechnology R&D > Transfection Technologies Market
Transfection Technologies Market size was valued at around USD 1.2 billion in 2023 and is estimated to grow at 8.9% CAGR from 2024 to 2032. Transfection technologies encompass a diverse array of methodologies employed in molecular biology and biotechnology to introduce exogenous nucleic acids, such as DNA, RNA, or oligonucleotides, into living cells.
The primary goal of transfection is to manipulate gene expression, study gene function, or develop therapeutic strategies by delivering genetic material into target cells. This process is fundamental to various research fields including genetic engineering, gene therapy, and drug discovery. The increasing prevalence of chronic diseases includes cardiovascular diseases, diabetes, and cancer serves as a substantial impetus for market growth. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths worldwide. Thus, the advancement and widespread adoption of transfection technologies are essential for enhancing the diagnosis, treatment management, and risk prediction of cancer.
Furthermore, rise in research and development in the field of cell-based therapies, technological advancement, and expanded applications of transfection technologies, are the contributing factors stimulating the growth of the market.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Transfection Technologies Market Size in 2023: | USD 1.2 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 8.9% |
2032 Value Projection: | USD 2.5 Billion |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 201 |
Tables, Charts & Figures: | 312 |
Segments covered: | Product, Method, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|